Newswise — April 12, 2022 – The ATS 2022 International Conference is coming back strong! Whether you cover clinical medicine or research, the programming at ATS 2022 is an extensive roundup of the latest in pulmonary, critical care and sleep medicine.
Media may register here. Your registration will also give you access to the on-demand highlights starting May 25 through June 24.
Can’t get to a session live? Chances are you can see the recording on-demand. Browse the conference program then reach out to us to secure expert interviews whether or not you’re joining us on site.
Note these Must-See Events and Build Your Itinerary:
- Clinical Trials Symposium – 9:30 a.m. PT, Monday, May 16
- Phase 3 SPRINTER trial in hospitalized patients with COVID-19
- Phase 2 efficacy and safety trial of BI 1015550, a phosphodiesterase 4B (PDE4B) inhibitor, in patients with idiopathic pulmonary fibrosis (NCT04419506). The FDA granted Breakthrough Therapy Designation to BI 1015550 in February 2022.
- Clinical Year in Review
- Nursing Year in Review
For more information about ATS 2022, visit the conference site or follow the meeting hashtag #ATS2022. For more information about press registration and media activities at the conference, see our media guidelines or contact Dacia Morris at [email protected].
*Note the press room officially opens at 6:30 A.M. PT on Sunday, May 15. Post-graduate courses are closed to media, unless previously arranged.
RSS